Clinical Trial Update: Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update reporting completion of a study evaluating allogeneic multivirus-directed cytotoxic T lymphocytes for Epstein-Barr virus, cytomeg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Allogeneic multivirus-directed cytotoxic T lymphocytes (CTL)

Snippet

Sponsor: Catherine Bollard | Conditions: EBV, CMV | Phase 1 | Status: COMPLETED